8 9 3 1
Corporation, Carlsbad, USA), 10% fetal calf serum (Gibco, New Zealand and Sigma-Aldrich, St. Louis, USA), and Penicillin-Streptomycin (Sigma-Aldrich) (now onwards referred to as R10). For some experiments, Vα7.2 + cells were isolated from PBMCs by labelling with anti-Vα7.2-PE 1 0 9 antibody (Clone; 3C10, BioLegend, San Diego, USA) followed by separation with anti-PE 1 1 0 magnetic beads using MS columns (both from Miltenyi Biotec, Bergisch Gladbach, Germany). 1 1 1 THP1 monocytic cells were maintained in R10. University of Otago and stored in single use aliquots at -80 °C, refer to Supplementary Methods 1 2 2 for details), or the combination of 50 ng/mL IL-12 (Miltenyi Biotec) and 50 ng/mL IL-18 (R & 1 2 3 D Systems, Minneapolis, USA), were added at the start of each experiment. Other than in the 1 2 4 time course experiments, PBMCs were treated with 5-A-RU or E. coli for 6 or 24 hours or IL-1 2 5 12+IL-18 for 24 hours. Some experiments were performed with 5-A-RU/MG (5-A-RU and 1 2 6 methyl glyoxal (MG, from Sigma-Aldrich) mixed at a molar ratio of 1:50 immediately prior to 1 2 7 use). For assessing the role of KDM6B, 10 5 CD8 + T cells were treated overnight with 5 µM 1 2 8 GSK-J4 (Sigma-Aldrich) and co-cultured with 100 bacteria per cell (BpC) E. coli fed 10 5 THP1 1 2 9 monocytes. MR1 mediated activation of MAIT cells was blocked with 2.5 µg/mL anti-MR1 1 3 0 antibody (clone 26.5, BioLegend, San Diego, USA). When assessing cytokine production and A total of 10 7 human PBMCs per donor (n=7) were treated with formaldehyde-fixed E. coli (10 1 7 5
BpC) or 5-A-RU (5 µM) for 6 hours or IL-12+IL-18 (50 ng/mL each) for 24 hours and MAIT 1 7 6 cells were isolated by fluorescence activated cell sorting RNA was sent to the Molecular 1 7 7
Genetics Facility at the Liggins Institute, Auckland, New Zealand for library preparation and Expression Kit and were sequenced on an Ion Proton. Read count data files were generated with 
TCR stimulation of MAIT cells results in chemokine production
3 9 8
Production of chemokines by MAIT cells upon activation has previously been shown (Lepore et (ligand for CCR1, CCR4 and CCR5), CCL4 (ligand for CCR5), and CCL20 (ligand for CCR6) 4 0 2 was seen with all treatments but was significantly higher in MAIT cells activated with E. coli 4 0 3
and 5-A-RU than with IL-12+IL-18 ( Figure 6A ). Consistent with this, CCL3, CCL4, and CCL20 4 0 4
production was detected in culture supernatant with E. coli or 5-A-RU treatment and was 4 0 5
reduced by approximately 10-fold upon MR1 blocking, confirming production was MAIT cell 4 0 6 specific ( Figure 6B ). Cytokine stimulation also triggered significant CCL3 and CCL4 4 0 7
production, albeit at lower levels ( Figure 6B ). We also observed enhanced CXCL9, CXCL10, 4 0 8 and CXCL11 gene expression, all ligands for CXCR3, with 5-A-RU and IL-12+IL-18 treatment, 4 0 9
whereas E. coli treatment resulted in a lesser, non-significant enhancement ( Figure 6C ). In 4 1 0 contrast, at the protein level, E. coli stimulated maximum CXCL9, CXCL10, and CXCL11 4 1 1 production by MAIT cells, followed by treatment with 5-A-RU and IL-12+IL-18 ( Figure 6D ); 4 1 2 MR1 blocking completely abolished production of CXCL9, CXCL10, and CXCL11 by E. coli 4 1 3
and 5-A-RU treated MAIT cells ( Figure 6D ). Additionally, E. coli but not 5-A-RU or IL-12+IL-18, resulted in upregulation of IL-8 (CXCL8) 4 1 5 gene expression ( Figure 6C ). Consistent with this, IL-8 production was highest in supernatant 4 1 6 from E. coli treated MAIT cells and was significantly blocked by anti-MR1 antibody ( Figure   4 1 7 6D). 5-A-RU and IL-12+IL-18 stimulation also caused low level but significant IL-8 production 4 1 8
( Figure 6D ). The finding of IL-8 production suggested that MAIT cells may be one of the first 4 1 9
responders to bacterial infection and may assist in recruiting other immune cells, including 18 stimulated MAIT cells were tested in a transwell migration system. Enhanced neutrophil that it was mediated by TCR signaling of MAIT cells ( Figure 6E ). CCL2 and XCL2, which both 4 2 6
have the potential to trigger migration of neutrophils by binding to CCR2 and XCR1 respectively 4 2 7 (Fox et al., 2015; H. Huang, Li, Cairns, Gordon, & Xiang, 2001; Talbot et al., 2015) , were also 4 2 8 upregulated with 5-A-RU stimulation compared to other treatments and may explain the increased neutrophil migration with supernatant from 5-A-RU treated MAIT cells (S. Figure 4) .
Overall, MAIT cells produce multiple chemokines upon activation by both TCR-dependent and - cells rapidly upregulated CD40L gene expression ( Figure 7A ). Unstimulated MAIT cells did not 4 3 8 express CD40L on the surface but treatment with E. coli for 6 hours led to significant CD40L 4 3 9 surface expression; in contrast little upregulation was seen with 5-A-RU ( Figure 7B ). MR1 4 4 0
blocking reduced E. coli mediated CD40L surface expression completely at both 6 hours and at 4 4 1 24 hours ( Figure 7B ). Significant CD40L was also seen on the surface of MAIT cells following 4 4 2 IL-12+IL-18 stimulation ( Figure 7B ). Soluble CD40L could not be detected in the culture media 4 4 3
with any treatments (data not shown).
4
We also observed increased expression of 4-1BB (TNFRSF9 or CD137), a co-stimulatory ( Figure 7D ). Late TCR activation by E. coli resulted in high expression of 4-1BB that was only 4 5 2 partially blocked with anti-MR1 antibody ( Figure 7D ). Therefore, TCR stimulation induces expression, albeit to a lesser extent. 
TCR stimulation of MAIT cells enhances expression of lysine demethylase 6B
4 5 6
Finally, expression of lysine demethylase 6B, KDM6B, also known as Jumonji domain 4 5 7
containing protein 3 (JMJD3), was specifically enriched upon TCR activation (S. Figure 3A ).
5 8
Inhibition of KDM6B by GSK-J4 demonstrated it was important for the upregulation of CD69 perforin production which was partially TCR-dependent and partially -independent. Activation 5 1 8
with the 5-A-RU for 24 hours induced significantly more granzyme B and perforin compared to is a time dependent process and for a strong response, either prolonged activation via the TCR, inflammatory response as discussed previously (Kurioka et al., 2015) . Additionally, both modes death receptor-mediated killing of infected cells (Varanasi, Khan, & Chervonsky, 2014) .
MAIT cells may also exercise direct killing of extracellular bacteria through the release of the substantial IFNγ production. Increased Blimp1 expression with E. coli and cytokines was 5 4 7 consistent with more granzyme B production than with 5-A-RU, whereas reduced EOMES MAIT cells were shown to be functionally similar to CD8 + MAIT cells (Kurioka et al., 2017) .
4
On the other hand, CD4 + MAIT cells (<5% of the MAIT cell population) expressed lower levels functional changes during activation, although this was not formally assessed in this study. respectively), which could lead to the subsequent upregulation of RORγt and IL-17A expression.
6 7
We also demonstrated that H3K27me3 is an important epigenetic modification during activation IFNg locus, leading to reduction of IL-17 and increased IFNγ production, consistent with our We found that MAIT cells produce multiple chemokines upon activation which may aid in with longer activation periods (16-24 hours or overnight). Here, we confirmed that MAIT cells 5 8 0 possess this immune cell recruiting capacity as early as 6 hours after activation. We also showed 5 8 1 that IL-12+IL-18 alone can stimulate modest chemokine production, particularly CCL3, CCL4, synergy to trigger robust chemokine production by MAIT cells (Havenith et al., 2012) .
8 6
In addition to this direct chemokine response, soluble mediators in the supernatant from 5 8 7 stimulated MAIT cells have been shown to trigger the production of various chemokines, such as MAIT cells and γ δ T cells were shown to migrate to infected peritoneal tissues in response to 5 9 0 locally elevated levels of CCL2, CCL3, CCL4, and CCL20 (Liuzzi et al., 2016) . High production 5 9 1 of CCL3, CCL4, and CCL20, along with moderate production of CXCL9 and CXCL10 by both Furthermore, significant production and release of TNFα and IL-1β observed with bacterial Both TCR and innate signals were found to upregulate helper molecules on MAIT cells. with L. longbeachae (Hinks et al., 2018) ; this confirms that the tissue repair function is a unique 6 1 4 signature of TCR activated MAIT cells. Therefore, it is now becoming clear that MAIT cells are 6 1 5
not just inflammatory and cytolytic T cells but are also helper cells involved in tissue repair and 6 1 6 maintaining homeostasis at the mucosal barrier and in the liver. 6 1 7
In this paper, we explored the response of TCR-and cytokine-stimulated MAIT cells from 6 1 8 peripheral blood. Future investigations will shed light on whether effector function profiles of 6 1 9
MAIT cells from different tissues also differ with the mode of activation and will enable us to 6 2 0 understand the role of MAIT cells as a friend, foe, or merely a bystander in disease progression.
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for assessing statistical significance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (E) 8 3 0
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